{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:50:22Z","timestamp":1782802222950,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL081064"],"award-info":[{"award-number":["HL081064"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL103453,"],"award-info":[{"award-number":["HL103453,"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/ZDS\/002794"],"award-info":[{"award-number":["K\/ZDS\/002794"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Center of Innovation Award by AB SCIEX"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12931-018-0909-6","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T13:16:09Z","timestamp":1540905369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Suzy A. A.","family":"Comhair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Baicker-McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Stachura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Hammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil C.","family":"Erzurum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Nizankowska-Mogilnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"issue":"3","key":"909_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","volume":"135","author":"JP Rajan","year":"2015","unstructured":"Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. J Allergy Clin Immunol. 2015;135(3):676\u201381 e671.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"909_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","volume":"118","author":"DD Stevenson","year":"2006","unstructured":"Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006;118(4):773\u201386 quiz 787-778.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"909_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.rmed.2012.10.020","volume":"107","author":"JY Moon","year":"2013","unstructured":"Moon JY, Kim SH, Kim TB, et al. Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey. Respir Med. 2013;107(2):202\u20138.","journal-title":"Respir Med"},{"issue":"3","key":"909_CR4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","volume":"16","author":"A Szczeklik","year":"2000","unstructured":"Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE investigators. European network on aspirin-induced asthma. Eur Respir J. 2000;16(3):432\u20136.","journal-title":"Eur Respir J"},{"issue":"5","key":"909_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","volume":"109","author":"G Bochenek","year":"2015","unstructured":"Bochenek G, Szafraniec K, Kuschill-Dziurda J, Nizankowska-Mogilnicka E. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease. Respir Med. 2015;109(5):588\u201395.","journal-title":"Respir Med"},{"issue":"5949","key":"909_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bmj.1.5949.67","volume":"1","author":"A Szczeklik","year":"1975","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J. 1975;1(5949):67\u20139.","journal-title":"Br Med J"},{"issue":"4","key":"909_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1172\/JCI620","volume":"101","author":"AS Cowburn","year":"1998","unstructured":"Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101(4):834\u201346.","journal-title":"J Clin Invest"},{"issue":"6 Pt 1","key":"909_CR8","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","volume":"148","author":"E Israel","year":"1993","unstructured":"Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993;148(6 Pt 1):1447\u201351.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"909_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","volume":"146","author":"M Kumlin","year":"1992","unstructured":"Kumlin M, Dahlen B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen SE. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis. 1992;146(1):96\u2013103.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"909_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jaip.2016.03.004","volume":"4","author":"R Divekar","year":"2016","unstructured":"Divekar R, Hagan J, Rank M, et al. Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity. J Allergy Clin Immunol Pract. 2016;4(4):665\u201370.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"909_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jaip.2017.07.001","volume":"6","author":"Grazyna Bochenek","year":"2018","unstructured":"Bochenek G, Stachura T, Szafraniec K, et al. Diagnostic accuracy of urinary LTE4 measurement to predict aspirin-exacerbated respiratory disease in patients with asthma. J Allergy Clin Immunol Pract. 2018;6(2):528\u201335. https:\/\/doi.org\/10.1016\/j.jaip.2017.07.001 .","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"16","key":"909_CR12","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","volume":"119","author":"TM Laidlaw","year":"2012","unstructured":"Laidlaw TM, Kidder MS, Bhattacharyya N, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790\u20138.","journal-title":"Blood"},{"issue":"15","key":"909_CR13","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","volume":"323","author":"J Bousquet","year":"1990","unstructured":"Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323(15):1033\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"909_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716\u201325.","journal-title":"Nat Med"},{"issue":"9","key":"909_CR15","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.4049\/jimmunol.166.9.5763","volume":"166","author":"JC MacPherson","year":"2001","unstructured":"MacPherson JC, Comhair SA, Erzurum SC, et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol. 2001;166(9):5763\u201372.","journal-title":"J Immunol"},{"issue":"10","key":"909_CR16","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1172\/JCI9702","volume":"105","author":"W Wu","year":"2000","unstructured":"Wu W, Samoszuk MK, Comhair SA, et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest. 2000;105(10):1455\u201363.","journal-title":"J Clin Invest"},{"issue":"10","key":"909_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","volume":"62","author":"E Nizankowska-Mogilnicka","year":"2007","unstructured":"Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62(10):1111\u20138.","journal-title":"Allergy"},{"issue":"2","key":"909_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","volume":"98","author":"E Macy","year":"2007","unstructured":"Macy E, Bernstein JA, Castells MC, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007;98(2):172\u20134.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"909_CR19","unstructured":"National Asthma Education and Prevention Programme. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/current\/asthma-guidelines2007 ."},{"issue":"1","key":"909_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","volume":"113","author":"RA Nathan","year":"2004","unstructured":"Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"909_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1513\/AnnalsATS.201310-354OC","volume":"11","author":"LE Katz","year":"2014","unstructured":"Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann Am Thorac Soc. 2014;11(4):531\u20136.","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"909_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","volume":"3","author":"DB Price","year":"2015","unstructured":"Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849\u201358.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"909_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","volume":"113","author":"MA Kim","year":"2014","unstructured":"Kim MA, Izuhara K, Ohta S, et al. Association of serum periostin with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2014;113(3):314\u201320.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"909_CR24","doi-asserted-by":"publisher","first-page":"e66644","DOI":"10.1371\/journal.pone.0066644","volume":"8","author":"SW Shin","year":"2013","unstructured":"Shin SW, Park JS, Park CS. Elevation of eosinophil-derived neurotoxin in plasma of the subjects with aspirin-exacerbated respiratory disease: a possible peripheral blood protein biomarker. PLoS One. 2013;8(6):e66644.","journal-title":"PLoS One"},{"issue":"1","key":"909_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cea.12797","volume":"47","author":"GY Ban","year":"2017","unstructured":"Ban GY, Cho K, Kim SH, et al. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease. Clin Exp Allergy. 2017;47(1):37\u201347.","journal-title":"Clin Exp Allergy"},{"issue":"5 Pt 1","key":"909_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143(5 Pt 1):1025\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"909_CR27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","volume":"5","author":"CM Smith","year":"1992","unstructured":"Smith CM, Hawksworth RJ, Thien FC, Christie PE, Lee TH. Urinary leukotriene E4 in bronchial asthma. Eur Respir J. 1992;5(6):693\u20139.","journal-title":"Eur Respir J"},{"issue":"2","key":"909_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","volume":"113","author":"N Higashi","year":"2004","unstructured":"Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2004;113(2):277\u201383.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"909_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/cea.12096","volume":"43","author":"GS Choi","year":"2013","unstructured":"Choi GS, Kim JH, Shin YS, Ye YM, Kim SH, Park HS. Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. Clin Exp Allergy. 2013;43(7):730\u201340.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"909_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.iac.2016.06.008","volume":"36","author":"JW Steinke","year":"2016","unstructured":"Steinke JW, Payne SC, Borish L. Eosinophils and mast cells in aspirin-exacerbated respiratory disease. Immunol Allergy Clin N Am. 2016;36(4):719\u201334.","journal-title":"Immunol Allergy Clin N Am"},{"issue":"2","key":"909_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1752-8062.2009.00095.x","volume":"2","author":"SH Wedes","year":"2009","unstructured":"Wedes SH, Khatri SB, Zhang R, et al. Noninvasive markers of airway inflammation in asthma. Clin Transl Sci. 2009;2(2):112\u20137.","journal-title":"Clin Transl Sci"},{"issue":"2","key":"909_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpeds.2011.01.029","volume":"159","author":"SH Wedes","year":"2011","unstructured":"Wedes SH, Wu W, Comhair SA, et al. Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children. J Pediatr. 2011;159(2):248\u201355 e241.","journal-title":"J Pediatr"},{"issue":"12","key":"909_CR33","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1021\/bi982401l","volume":"38","author":"W Wu","year":"1999","unstructured":"Wu W, Chen Y, d'Avignon A, Hazen SL. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry. 1999;38(12):3538\u201348.","journal-title":"Biochemistry"},{"issue":"36","key":"909_CR34","doi-asserted-by":"publisher","first-page":"25933","DOI":"10.1074\/jbc.274.36.25933","volume":"274","author":"W Wu","year":"1999","unstructured":"Wu W, Chen Y, Hazen SL. Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem. 1999;274(36):25933\u201344.","journal-title":"J Biol Chem"},{"issue":"6","key":"909_CR35","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1365-2222.2004.01968.x","volume":"34","author":"H Mita","year":"2004","unstructured":"Mita H, Higashi N, Taniguchi M, Higashi A, Kawagishi Y, Akiyama K. Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin Exp Allergy. 2004;34(6):931\u20138.","journal-title":"Clin Exp Allergy"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-018-0909-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-018-0909-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:05:09Z","timestamp":1694012709000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-018-0909-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1186\/s12931-018-0909-6","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"25 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee at Jagiellonian University approved the study, which was carried out according to the declaration of Helsinki. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SLH is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and asthmatic therapeutics, and has the right to receive royalty payment for inventions or discoveries both related tocardiovascular and asthmatic diagnostics or therapeutics from the Cleveland Clinic, Quest Diagnostics and Proctor & Gamble. SLH also reports having been paid as a Consultant from Proctor & Gamble, and having received research funds from Proctor & Gamble and Roche.DD.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"210"}}